Verastem reported $2K in Gross Profit on Sales for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
TG Therapeutics TGTX:US 1.74M 341K
AstraZeneca AZN:LN 6.04B 15M
Curis CRIS:US $ 2.89M 0.72M
Epizyme EPZM:US $ 3.2M 7.32M
Gilead Sciences GILD:US $ 6198M 1371M
Laboratory Of America LH:US $ 1385.5M 120.7M
Novartis NOVN:VX 9.52B 21M
Pfizer PFE:US $ 14163M 2178M
Verastem VSTM:US $ 0M 0.5M
YTE INCY:US $ 778.52M 105.44M